ScholarLens Back to search
2017•Kidney International ReportsOpen access

A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake

Kazuhito Fukuoka, Yuriko Sato, Hiroyuki Sakurai, Soko Kawashima, Shinya Kaname, Yoshihiro Arimura

Open full text 1 citations

Abstract

It is well known that the strict control of serum inorganic phosphorus (IP) and potassium (K) concentrations is important for the prevention of various complications and improving the prognosis of patients with chronic kidney disease (CKD). Hyperkalemia is associated with sudden cardiac death in hemodialysis (HD) patients and hyperphosphatemia is associated with an increase in cardiovascular events and mortality in CKD patients.1,2 It is a common practice to restrict IP and K intake when HD patients present with these electrolyte abnormalities.

Open-access reader

About this research paper

What this paper is about

It is well known that the strict control of serum inorganic phosphorus (IP) and potassium (K) concentrations is important for the prevention of various complications and improving the prognosis of patients with chronic kidney disease (CKD). Hyperkalemia is associated with sudden cardiac death in hemodialysis (HD) patients and hyperphosphatemia is associated with an increase in cardiovascular events and mortality in CKD patients.1,2 It is a common practice to restrict IP and K intake when HD patients present with these electrolyte abnormalities.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

It is well known that the strict control of serum inorganic phosphorus (IP) and potassium (K) concentrations is important for the prevention of various complications and improving the prognosis of patients with chronic kidney disease (CKD). Hyperkalemia is associated with sudden cardiac death in hemodialysis (HD) patients and hyperphosphatemia is associated with an increase in cardiovascular events and mortality in CKD patients.1,2 It is a common practice to restrict IP and K intake when HD patients present with these electrolyte abnormalities.

Key concepts: Hyperphosphatemia, Hyperkalemia, Medicine, Azotemia, Hemodialysis, Kidney disease, Dialysis, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake — Research Paper | ScholarLens